Terapia cognitivo-conductual en las psicosis agudas

  1. Gutiérrez López, María Isabel
  2. Sánchez Muñoz, María
  3. Trujillo Borrego, Alejandra
  4. Sánchez Bonome, Luis
Journal:
Revista de la Asociación Española de Neuropsiquiatría

ISSN: 0211-5735

Year of publication: 2012

Volume: 32

Issue: 114

Pages: 225-245

Type: Article

DOI: 10.4321/S0211-57352012000200002 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Revista de la Asociación Española de Neuropsiquiatría

Sustainable development goals

Abstract

Some years ago, the treatment for acute psychosis was something left for pharmacological treatment (except for psychoanalysis). Lately, this trend has been changing and some studies have shown the advantages of cognitive behavioural therapy in the acute psychosis. A new and promising way of intervention is merging to this trend: early intervention of psychosis. In this study, we show a bibliographical review of the most important researches published until today on this topic. We have included the works with a random and controlled design and those which guaranteed the reliability and validity requirements. The results of these studies are full of hope since they show the efficiency of cognitive behavioural therapy as a way of treatment. However, more research is needed to prove these facts

Bibliographic References

  • (1) McGorry PD, Killackey E, Yung A. Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry 2008; 7: 148-156.
  • (2) Haddock G, Morrison A, Hopkins R, Lewis S, Tarrier N. Individual cognitive-behavioural interventions in early psychosis. Br J Psychiatry 1998; 172 Suppl 33: 101-106.
  • (3) Drury V, Birchwood M, Cochrane R, McMillan F. Cognitive therapy and recovery from acute psychosis: a controlled trial. I: Impact on psychotic symptoms. Br J Psychiatry 1996a; 169: 593-601.
  • (4) Drury V, Birchwood M, Cochrane R, McMillan F. Cognitive therapy and recovery from acute psychosis: a controlled trial. II: Impact on recovery time. Br J Psychiatry 1996b; 169: 602-607.
  • (5) Liberman, R. P., Wallace, C. J., Falloon, I. R. H. y Vaughn, E. Psychiatric Assessment Scale (PAS). Comprehensive Psychiatry 1981; 22 (6).
  • (6) Drury V, Birchwood M, Cochrane R. Cognitive therapy and recovery from acute psychosis: a controlled trial. Five-year follow-up. Br J Psychiatry 2000; 177: 8-14.
  • (7) Kemp R, Hayward P, Applewhaite G, Everitt B, David A. Compliance therapy in psychotic patients: randomised controlled trial. BMJ 1996; 312: 345-349
  • (8) Rollnick S, Heather N, Bell A. Negotiating behaviour change in medical settings: The development of brief motivational interviewing. J Ment Health 1992; 1: 25-37.
  • (9) Kemp R, Kirov G, Everitt B, Hayward P, David A. Randomised controlled trial of compliance therapy. 18-month follow-up. Br J Psychiatry 1998; 172: 413-419.
  • (10) O`Donnell C, Donohoe G, Sharkey L, Owens N Migone M, Harries R, Kinsella A, et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ 2003; 327 (7419):834.
  • (11) Kay S, Fiszbein A, Opler L. The Positive and Negative Syndrome Scale (PANSS). Schizophr Bull 1987; 13: 261-273
  • (12) David AS. Insight and psychosis. Br J Psychiatry 1990; 156: 798-808.
  • (13) American Psychiatric Association. Diagnostic and Stadistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
  • (14) Heinrichs DW, Hanlon TE, Carpenter WT Jr. The quality of Life Scale: and instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 1984; 10: 338-398.
  • (15) Lewis S, Tarrier N, Haddock G, Bentall R, Kinderman P, Kingdon D, et al. Randomised controlled trial of cognitive behavioural therapy in early schizophrenia: acute-phase outcomes. Br J Psychiatry 2002 Sept; Suppl 43: 91-97.
  • (16) Tarrier N, Lewis S, Haddock G, Bentall R, Kinderman P, Kingdon D, et al. Cognitive behavioural therapy in first episode and early schizophrenia. Br J Psychiatry 2004; 184: 231-239.
  • (17) Tarrier N, Lewis S, Haddock G, Bentall R, Drake R, et al. Cognitive behavioural therapy in firstepisode and early schizophrenia 18-month follow-up of a randomised controlled trial. Br J Psychiatry 2004; 184: 231-239.
  • (18) Tarrier N, Haddock G, Lewis S, Drake R, Gregg L. Suicide behaviour over 18 months in recent onset schizophrenic patients: The effects of CBT. Schizophr Res 2006; 83: 15-27.
  • (19) Haddock G, Lewis S, Bentall R, Dunn G, Drake R, Tarrier N. Influence of age on outcome of psychological treatments in first-episode psychosis. Br J Psychiatric 2006; 188: 250-254.
  • (20) Startup M, Jackson MC, Bendix, S. North Wales randomised controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: outcomes at 6 and 12 months. Psychol Med 2004; 34: 413-422
  • (21) Fowler D, Garety P, Kuipers E. Cognitive Behaviour Therapy for Psychosis: Theory and Practice. Chichester: Wiley, 1995.
  • (22) Andreasen NC. Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa: Iowa City; 1984.
  • (23) Andreasen NC (1984). Scale for the Assessment of Negative Symptoms (SANS). University of Iowa: Iowa.
  • (24) Lukoff D, Nuechterlein KH, Ventura J. Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr Bull 1986; 12:578-602.
  • (25) Startup M, Jackson MC, Evans KE, Bendix S. North Wales randomised controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: two year follow-up and economic evaluation. Psychol Med 2005; 35: 1307-1316.
  • (26) Prendergast LA, Griffith GL, Evans KE, Carter MF, Crosby C. A study of continuing care clients of community mental health teams. Unpublished report. Health Services Research Unit (1999), University of Wales, Bangor, UK.
  • (27) Henry L, Edwars J, Jackson HJ, Hulbert C, McGorry PD. Cognitively-oriented psychotherapy for early psychosis (COPE): a Practitioner´s Manual, EPPIC: the Early Psychosis Prevention and Intervention Center, 2002
  • (28) McGorry P, Edwards J, Mihalopoulis C, Harrigan SM, Jackson HJ. EPPIC: An envolving system of early detection and optimal management. Schizophr Bull 1996, 22: 305-326.
  • (29) Jackson H, McGorry P, Edwards J, Hulbert C, Henry L, Francey S et al. Cognitively-oriented psychotherapy for early psychosis (COPE). Preliminary results. Br J Psychiatry 1998; 172 Suppl 33: 93-100.
  • (30) Jackson H, McGorry P, Henry L, Edwards J, Hulbert C, Harrigan S, et al. Cognitivelyoriented psychotherapy for early psychosis (COPE): A one-year follow-up. Br J Clinic Psychol 2001; 40: 57-70.
  • (31) Kleinman A. Patients and Healers in the Context of Culture. An Exploration of the Borderline between Anthropology, Medicine and Psychiatry. University of California Press Ltd: Berkeley, California; 1980.
  • (32) Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571.
  • (33) Derogatis LR. The SCL-90-R. Baltimore, MD: Clinical Psychometric Research, 1975.
  • (34) Jackson H, McGorry P, Henry L, Edwards J, Hulbert C, Henry L, et al. A controlled trial of cognitively oriented psychotherapy for early psychosis (COPE) with four-year follow-up readmission data. Psychol Med 2005; 35: 1295-1306.
  • (35) Jackson HJ, McGorry PD, Killackey E, Bendall S, Allott K, Dudgeon P, et al. Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project Psychol Med 2008; 38(5):725-35.
  • (36) First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSMIV-TR Axis I Disorders-Research Version, Patient Edition (SCID-I/P). Biometrics Research Department, New York State Psychiatric Institute: New York: 2001.
  • (37) Harrigan SM, McGorry PD, Krestev H. Does treatment delay in first-episode psychosis really matter? Psychol Med 2003; 33, 97–110.
  • (38) Ventura J, Lukoff D, Nuechterlein KH, Liberman RP, Green MF, Shaner A. Brief Psychiatric Rating Scale (BPRS) Expanded Version (4.0). Scales, Anchor Points, and Administration Manual. UCLA Department of Psychiatry and Behavioral Sciences: West Los Angeles: 1993.
  • (39) APA. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association : Washington, DC: 1994.
  • (40) Bendall S, Killackey E, Marois MJ, Jackson H. ACE Manual (Active Cognitive Therapy for Early Psychosis). ORYGEN Research Centre and Department of Psychology, University of Melbourne: Melbourne; 2005.
  • (41) Bendall S, Killackey E, Jackson H, Gleeson J. Befriending Manual. ORYGEN Research Centre and Department of Psychology, University of Melbourne: Melbourne; 2003.
  • (42) Glesson JFM, Cotton SM, Alvarez-Jimenez M, Wade D, Gee D, Crisp K, et al. A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients. J Clin Psychiatry 2009; 70(4): 477-486.
  • (43) Early Psychosis Prevention and Intervention Centre. Case management in early psychosis: a handbook. EPPIC: Parkville, Victoria, Australia: 2001.
  • (44) First MB, Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). User´s Guide and Interview. Washington, DC: American Psychiatric Press: 1997.
  • (45) Montgomery SM. Depressive symptoms in acute schizophrenia. Prog Neuropsychopharmacol, 1979; 3:429-433.
  • (46) Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000; 42: 241-247.
  • (47) Ginsberg JP. Wechsler Test of Adult Reading. Applied Neuropsychol 2003; 10:182-184.
  • (48) Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 1982; 8: 470-484.
  • (49) Goldman HH, Skodol AE, Lave TR. Revising Axis-V for DSM-IV: a review of measures of social functioning. Am J Psychiatry 1992; 149: 1148-1156.
  • (50) Development of the World health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med 1998; 28(3): 551-558.
  • (51) Ali R, Awwad E, Babor T, Bradley F, Butau T, Farrell M, et al. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction 2002; 97: 1183-1194.
  • (52) Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection on Persons with Harmful Alcohol Consumption. Addiction 1993; 88(6): 791-804.
  • (53) Bertelsen M, Jeppesen P, Petersen L, Thorup A, Ohlenschlager J, Quach P, et al. Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness. Arch Gen Psychiatry 2008, 65(7):762-71.
  • (54) Melau M, Jeppesen P, Thorup A, Bertelsen M, Petersen L, Gluud C, et al. The effect of five years versus two years of specialised assertive intervention for first episode psicosisOPUS II: study protocol for a randomized controlled trial. Trials 2011, 12:72.
  • (55) McGorry P, Yung A, Phillips L, Yuen, H, Francey S, Cosgrave E, et al. Randomised controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002; 59: 921-928.
  • (56) Hamilton M. The Assessment of Anxiety States by Rating. Br J Psychiatry 1959; 32: 50-55.
  • (57) Young RC, Biggs JT, Ziegler VE, Meyer DA. A Rating Scale for Mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
  • (58) Wing JK, Babor T, Brugha T, Burke J. SCAN: Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 1990; 47: 589-593.
  • (59) Yung AR. The Comprehensive Assessment of At-risk Mental States (CAARMS). Melbourne, Australia: University of Melbourne; 2000.
  • (60) Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high-risk: Randomised controlled trial. Br J Psychiatry 2004; 185: 291-297.
  • (61) Goldberg DP, Hillier VF. A scale version of the general health questionnaire. Psychol Med 1979; 9: 139-145.
  • (62) Beck AT. Cognitive Therapy and the Emotional Disorder. New York: International Universities Press; 1976.
  • (63) Morrison AP, French P, Parker S, Roberts M, Stevens H, Bentall RP et al. Three-Year Follow-up of a Randomized controlled trial og cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr Bull 2007; 33(3): 682-687.
  • (64) Addington J, Epstein I, Liu L, French P, Boydell KM, Zypursky RB. A randomized controlled trial of CBT for individuals at clinical high risk of psychosis. Schizopr Res 2011; 125: 54-61.
  • (65) Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry 1993; 163, 39–44.
  • (66) Olivares J, Garcia-Lopez LJ, Hidalgo MD. The Social Phobia Scale and the Social Interaction Anxiety Scale: factor structure and reliability in a Spanish speaking population. J Psychoeduc Assess 2001; 19, 69–80.
  • (67) Birchwood M, Smith J, Cochrane R, Wetton C, Copestake C. The Social Functioning Scale: the development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry 1990; 157: 853-859.
  • (68) Tracey T, Kokotovic A. Factor Structure of the Working Alliance Inventory. Psychological Assessment 1989; 1: 207–210.
  • (69) Gumley A, O`Grady M, McNay L, Reilly J, Power K, Morrie J. Early intervention for relapse in schizophrenia: results of a 12-month randomised controlled trial of cognitive behavioural therapy. Psychol Med 2003; 33: 419-431.
  • (70) Derogatis L, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983; 13: 595-605.
  • (71) Birchwood M, Mason R, Macmillan F. Depression, the moralisation and control over psychotic illness. Psychol Med 1993; 23: 387-395.
Data source: Dialnet